Cargando…

Biapenem versus meropenem in the treatment of bacterial infections: a multicenter, randomized, controlled clinical trial

BACKGROUND & OBJECTIVES: Biapenem is a newly developed carbapenem to treat moderate and severe bacterial infections. This multicenter, randomized, parallel-controlled clinical trial was conducted to compare the clinical efficacy, bacterial eradication rates and safety of biapenem and meropenem i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xiaohui, Zhang, Xiaoke, Zong, Zhiyong, Yu, Rujia, Lv, Xiaoju, Xin, Jianbao, Tong, Chaohui, Hao, Qinglin, Qin, Zhiqiang, Xiong, Ying, Liu, Hong, Ding, Guohua, Hu, Chengping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978993/ https://www.ncbi.nlm.nih.gov/pubmed/24521647

Ejemplares similares

Real-world Biapenem vs. Meropenem in the treatment of severe community-acquired pneumonia in children: A propensity score matching analysis
por: Tao, Xuemei, et al.
Publicado: (2022)

PK/PD analysis of biapenem in patients undergoing continuous hemodiafiltration
por: Akashita, Gaku, et al.
Publicado: (2015)

Metabolomic Insights Into the Synergistic Effect of Biapenem in Combination With Xuebijing Injection Against Sepsis
por: Liu, Li-Wei, et al.
Publicado: (2020)

Biapenem Inactivation by B2 Metallo β-Lactamases: Energy Landscape of the Hydrolysis Reaction
por: Ackerman, Sharon H., et al.
Publicado: (2013)

Biapenem Inactivation by B2 Metallo β-Lactamases: Energy Landscape of the Post-Hydrolysis Reactions
por: Gatti, Domenico L.
Publicado: (2012)

Biapenem as a Novel Insight into Drug Repositioning against Particulate Matter-Induced Lung Injury
por: Lee, Wonhwa, et al.
Publicado: (2020)

Studies on the Reactions of Biapenem with VIM Metallo β-Lactamases and the Serine β-Lactamase KPC-2
por: Lucic, Anka, et al.
Publicado: (2022)

Biapenem, a Carbapenem Antibiotic, Elicits Mycobacteria Specific Immune Responses and Reduces the Recurrence of Tuberculosis
por: Pahuja, Isha, et al.
Publicado: (2023)

Structural insight into the inactivation of Mycobacterium tuberculosis non-classical transpeptidase Ldt(Mt2) by biapenem and tebipenem
por: Bianchet, Mario A., et al.
Publicado: (2017)

Meropenem-Vaborbactam in the Treatment of Acute Bacterial Infections
por: Lai, Chih-Cheng, et al.
Publicado: (2019)

Clonal diversity of Acinetobacter baumannii clinical isolates revealed by a snapshot study
por: Wang, Xiaohui, et al.
Publicado: (2013)

ICU-Onset Clostridium difficile Infection in a University Hospital in China: A Prospective Cohort Study
por: Wang, Xiaohui, et al.
Publicado: (2014)

Is Meropenem as a Monotherapy Truly Incompetent for Meropenem-Nonsusceptible Bacterial Strains? A Pharmacokinetic/Pharmacodynamic Modeling With Monte Carlo Simulation
por: Song, Xiangqing, et al.
Publicado: (2019)

Real-world Multicenter Analysis of Clinical Outcomes and Safety of Meropenem-Vaborbactam in Patients Treated for Serious Gram-Negative Bacterial Infections
por: Alosaimy, Sara, et al.
Publicado: (2020)

Real-world, Multicenter Experience With Meropenem-Vaborbactam for Gram-Negative Bacterial Infections Including Carbapenem-Resistant Enterobacterales and Pseudomonas aeruginosa
por: Alosaimy, Sara, et al.
Publicado: (2021)

Determination of MIC Distribution of Arbekacin, Cefminox, Fosfomycin, Biapenem and Other Antibiotics against Gram-Negative Clinical Isolates in South India: A Prospective Study
por: Rajenderan, Sangeetha, et al.
Publicado: (2014)

In Vitro Synergistic Activity of Biapenem Combination with Sulbactam, Colistin, and Fosfomycin Sodium Against Multidrug-resistant Acinetobacter baumannii Isolates from Tertiarycare Hospitals in Thailand
por: Houngsaitong, Jantana, et al.
Publicado: (2017)

Clinical Outcomes and Safety of Meropenem–Colistin versus Meropenem–Tigecycline in Patients with Carbapenem-Resistant Acinetobacter baumannii Pneumonia
por: Park, Jae-Min, et al.
Publicado: (2021)

Meropenem versus imipenem/cilastatin in the treatment of serious bacterial infections in ICU: an open randomised multicentre study
por: Verwaest on behalf of the Belgiun Multicentre study group, C
Publicado: (1997)

Curcumin-meropenem synergy in carbapenem resistant Klebsiella pneumoniae curcumin-meropenem synergy
por: Gülen, Dumrul, et al.
Publicado: (2021)

Empirical cefepime+vancomycin versus ceftazidime+vancomycin versus meropenem+vancomycin in the treatment of healthcare-associated meningitis: results of the multicenter Ephesus study
por: Sipahi, Oguz Resat, et al.
Publicado: (2023)

Synergistic Antibacterial Activity of Combined Antimicrobials and the Clinical Outcome of Patients With Carbapenemase-Producing Acinetobacter baumannii Infection
por: Qu, Junyan, et al.
Publicado: (2020)

Characterization of a New SCCmec Element in Staphylococcus cohnii
por: Zong, Zhiyong, et al.
Publicado: (2010)

Meropenem: continuous or extended infusion?
por: Frippiat, Frédéric, et al.
Publicado: (2020)

Meropenem: Leucopenia: case report
Publicado: (2021)

Meropenem-induced hypokalemia and metabolic alkalosis
por: Zaki, Syed Ahmed, et al.
Publicado: (2012)

The Radiostability of Meropenem Trihydrate in Solid State
por: Kilińska, Karolina, et al.
Publicado: (2018)

Impact of meropenem on Klebsiella pneumoniae metabolism
por: Foschi, Claudio, et al.
Publicado: (2018)

Diversity of SCCmec Elements in Methicillin-Resistant Coagulase-Negative Staphylococci Clinical Isolates
por: Zong, Zhiyong, et al.
Publicado: (2011)

The emergence of bla(CTX-M-15)-carrying Escherichia coli of ST131 and new sequence types in Western China
por: Zhang, Lei, et al.
Publicado: (2013)

Ceftazidime–Avibactam versus Meropenem for the Treatment of Complicated Intra-Abdominal Infections
por: Tan, Che-Kim, et al.
Publicado: (2019)

Whole genome sequences of three Clade 3 Clostridium difficile strains carrying binary toxin genes in China
por: Chen, Rong, et al.
Publicado: (2017)

Extended Infusion of Meropenem in Neonatal Sepsis: A Historical Cohort Study
por: Cao, Guangna, et al.
Publicado: (2022)

1603. Comparison of Ceftolozane/Tazobactam, Ceftazidime/Avibactam, and Meropenem/Vaborbactam Activity Against P. aeruginosa: A Multicenter Evaluation
por: Moise, Pamela, et al.
Publicado: (2020)

The First Outbreak Caused by Acinetobacter baumannii ST208 and ST195 in China
por: Qu, Junyan, et al.
Publicado: (2016)

Cost Effectiveness of Ceftolozane/Tazobactam Compared with Meropenem for the Treatment of Patients with Ventilated Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
por: Naik, Jaesh, et al.
Publicado: (2021)

Administration of meropenem for the treatment of ventilator-associated pneumonia
por: Zolotukhin, K, et al.
Publicado: (2007)

Simultaneous determination of linezolid, meropenem and theophylline in plasma
por: Attia, Ali K., et al.
Publicado: (2018)

An investigation of the stability of meropenem in elastomeric infusion devices
por: Foy, Finbarr, et al.
Publicado: (2019)

An Appraisal of the Pharmacokinetic and Pharmacodynamic Properties of Meropenem-Vaborbactam
por: Wenzler, Eric, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7o38l8p4strkh0qdmv3l65msui